Back to Journals » Clinical Interventions in Aging » Volume 12

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]

Authors Omboni S, Malacco E, Mallion J, Volpe M

Received 2 June 2017

Accepted for publication 2 June 2017

Published 2 August 2017 Volume 2017:12 Pages 1205—1206

DOI https://doi.org/10.2147/CIA.S143099


Omboni S, Malacco E, Mallion JM, Volpe M. Clinical Interventions in Aging. 2015;10:1575–1586.

On page 1584, left column, 4th row from the bottom, the age indicated should be 65–69 rather than 65–59.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]